International Clinical Trial: A Study to Evaluate the Immune Response and Safety of a Vaccine Against Influenza in Adults 18-64 Years of Age

Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (NCT07851246) titled 'A Study to Evaluate the Immune Response and Safety of a Vaccine Against Influenza in Adults 18-64 Years of Age' on Sept. 25.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: Triple (Participant, Investigator, Outcomes Assessor).

Primary Sponsor: GlaxoSmithKline

Condition: Influenza, Human

Intervention: Biological: mRNA Seasonal Flu vaccine Biological: Comparator 1

Recruitment Status: Not recruiting

Phase: Phase 3

Date of First Enrollment: October 1, 2026

Target Sample Size: 3000

To know more, visit https://cli...